Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, February 8, 2013

Intra-Arterial Stroke Tx Takes Hit, but Survives

I know I posted about this earlier but it bears repeating. That until the neuronal cascade of death is solved these interventions won't show the best results. Dr. Joseph P. Broderick, do you even understand what you are up against? Just blowing out the clot does not solve the stroke problem.
http://www.medpagetoday.com/Cardiology/Strokes/37263
The buzz here at the International Stroke Conference is the poor showing of endovascular therapies for treating acute ischemic stroke. But there are "glimmers" that certain patients might benefit, said Joseph P. Broderick, MD, in this exclusive InFocus interview.
Broderick was the principle investigator for the Interventional Management of Stroke (IMS) III trial, which found no difference in outcomes for the combined endovascular therapy plus intravenous tPA approach versus IV tPA alone.
But it's too soon to give up hope, Broderick told Chris Kaiser, MedPage Today cardiology editor, because several clinical trials will have results later this year, and other trials are in the planning stages.

No comments:

Post a Comment